Medtronic’s plans to separate its combined patient monitoring and respiratory interventions businesses will likely go forward, Seeking Alpha reported June 12.
The planned spinoff will allow for greater investment focus in the areas of “highest strategic priority” and help execute Medtronic’s leadership strategy in attractive medtech markets, the company said in an October.
Discussions with Carlyle Group, a private equity firm, have slowed, the report said. The devicemaker was looking to sell the businesses for about $10 billion.
million in 2024, according to a recent Securities and Exchange Commission proxy filing. The devicemaker’s March 25 filing revealed the…
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive procedure. …
Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has entered…
Comments are closed.